AJANTA PHARMA LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has sixty-three approved drugs.
There are three tentative approvals on AJANTA PHARMA LTD drugs.
Summary for AJANTA PHARMA LTD
| US Patents: | 0 |
| Tradenames: | 53 |
| Ingredients: | 52 |
| NDAs: | 63 |
| Drug Master File Entries: | 2 |
Drugs and US Patents for AJANTA PHARMA LTD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 217293-001 | Apr 27, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ajanta Pharma Ltd | TOPIRAMATE | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 215663-002 | Aug 15, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ajanta Pharma Ltd | OLANZAPINE | olanzapine | TABLET;ORAL | 206711-005 | Aug 30, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ajanta Pharma Ltd | OXCARBAZEPINE | oxcarbazepine | TABLET, EXTENDED RELEASE;ORAL | 217659-001 | Feb 22, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ajanta Pharma Ltd | ELETRIPTAN HYDROBROMIDE | eletriptan hydrobromide | TABLET;ORAL | 205186-001 | Aug 29, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
